BNTX — Recent News Coverage
All news mentioning BNTX in ESEN's AI-graded feed
News stories with BNTX as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on BNTX. See /coverage/BNTX for the 30-day aggregate.
MANILATIMES.NET
·
2026-10-25
NEUTRAL
BULLISH
CORR0.45
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
$BNTX
$BMY
◈ ESEN AI
BNTX and BMY announced Phase 2 data for pumitamig, a candidate targeting advanced non-small cell lung cancer (NSCLC) in a post-immunotherapy setting. The trial demonstrated a 36.7% objective response rate and 6.9-month …
INSIDERMONKEY.COM
·
2026-08-11
NEUTRAL
NEUTRAL
CORR0.42
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
$PFE
$BNTX
◈ ESEN AI
Pfizer (PFE) and BioNTech (BNTX) have released Q2 2026 earnings and strategic announcements, marking continued divergence in their post-pandemic business models. This comparison piece examines how each company is reposi…
RTTNEWS.COM
·
2026-08-04
HIGH
BEARISH
CORR0.58
BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market
$BNTX
$BMY
◈ ESEN AI
BioNTech reported a significant deterioration in Q2 financial performance, with net losses more than doubling year-over-year to €820.8 million. This widening loss, coupled with a downward revision to full-year 2026 reve…
MANILATIMES.NET
·
2026-08-03
NEUTRAL
NEUTRAL
CORR0.35
BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer
$BNTX
◈ ESEN AI
BioNTech announced a leadership transition, with Guido Oelkers appointed as Chief Executive Officer effective by February 1, 2027, replacing founder Prof. Ugur Sahin. Oelkers joins from Swedish Orphan Biovitrum (SOBI), …
MANILATIMES.NET
·
2026-07-21
NEUTRAL
BULLISH
CORR0.58
PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight
$JNJ
$LLY
$INCY
$BNTX
◈ ESEN AI
The report analyzes a competitive landscape of 200+ PD-1 and PD-L1 inhibitor drugs across clinical development and approved therapies, identifying 180+ companies positioned to influence oncology therapeutics. This depth…
SEEKINGALPHA.COM
·
2026-07-21
NEUTRAL
BEARISH
CORR0.15
BioNTech: The Market Is Paying Too Much For An Unproven Pipeline (NASDAQ:BNTX)
$BNTX
◈ ESEN AI
BioNTech (BNTX) has received a bearish initiation with a Sell rating and a fair value range of $55–$70, implying approximately 32% downside risk from current levels. The thesis centers on pipeline valuation risk and exe…
MANILATIMES.NET
·
2026-07-21
NEUTRAL
NEUTRAL
CORR0.18
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
$BNTX
◈ ESEN AI
BioNTech has scheduled its Q2 2026 earnings announcement for August 4, 2026, a standard quarterly reporting cadence that provides investors with periodic visibility into operational performance and financial trajectory.…
REUTERS
·
2026-07-08
LOW
BEARISH
CORR-0.15
Congo says number of confirmed Ebola cases rises to 1,708 - Reuters
$JNJ
$BNTX
◈ ESEN AI
The Democratic Republic of Congo's confirmed Ebola cases have risen to 1,708, signaling continued spread of the viral outbreak in the region. This represents an escalation in public health crisis severity, though contai…
EXPLORE OTHER FILTERS